MA27404A1 - Nouveaux inhibiteurs bicycliques de la lipase sensible aux hormones - Google Patents

Nouveaux inhibiteurs bicycliques de la lipase sensible aux hormones

Info

Publication number
MA27404A1
MA27404A1 MA28213A MA28213A MA27404A1 MA 27404 A1 MA27404 A1 MA 27404A1 MA 28213 A MA28213 A MA 28213A MA 28213 A MA28213 A MA 28213A MA 27404 A1 MA27404 A1 MA 27404A1
Authority
MA
Morocco
Prior art keywords
lipase inhibitors
sensitive lipase
hormone sensitive
novel bicyclic
bicyclic
Prior art date
Application number
MA28213A
Other languages
English (en)
Inventor
Stefan Petry
Karl-Heinz Baringhaus
Norbert Tennagels
Guenter Mueller
Hubert Heuer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of MA27404A1 publication Critical patent/MA27404A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
MA28213A 2002-10-12 2005-04-11 Nouveaux inhibiteurs bicycliques de la lipase sensible aux hormones MA27404A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10247680A DE10247680B4 (de) 2002-10-12 2002-10-12 Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase

Publications (1)

Publication Number Publication Date
MA27404A1 true MA27404A1 (fr) 2005-06-01

Family

ID=32038583

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28213A MA27404A1 (fr) 2002-10-12 2005-04-11 Nouveaux inhibiteurs bicycliques de la lipase sensible aux hormones

Country Status (38)

Country Link
EP (1) EP1554259B1 (fr)
JP (2) JP4658607B2 (fr)
KR (1) KR20050059254A (fr)
CN (1) CN100366616C (fr)
AR (1) AR041565A1 (fr)
AT (1) ATE349433T1 (fr)
AU (1) AU2003275997B8 (fr)
BR (1) BR0315257A (fr)
CA (1) CA2501734C (fr)
CR (1) CR7717A (fr)
CY (1) CY1106358T1 (fr)
DE (2) DE10247680B4 (fr)
DK (1) DK1554259T3 (fr)
EC (1) ECSP055729A (fr)
ES (1) ES2277152T3 (fr)
GT (1) GT200300214A (fr)
HN (1) HN2003000316A (fr)
HR (1) HRP20050325A2 (fr)
IL (1) IL167907A (fr)
JO (1) JO2497B1 (fr)
MA (1) MA27404A1 (fr)
MX (1) MXPA05003359A (fr)
MY (1) MY138057A (fr)
NO (1) NO20052291D0 (fr)
OA (1) OA12941A (fr)
PA (1) PA8585101A1 (fr)
PE (1) PE20040776A1 (fr)
PL (1) PL374605A1 (fr)
PT (1) PT1554259E (fr)
RS (1) RS51543B (fr)
RU (1) RU2325385C2 (fr)
SV (1) SV2004001633A (fr)
TN (1) TNSN05105A1 (fr)
TW (1) TWI313265B (fr)
UA (1) UA79994C2 (fr)
UY (1) UY28015A1 (fr)
WO (1) WO2004035550A1 (fr)
ZA (1) ZA200501757B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005002130A1 (de) 2005-01-17 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
DE102005026808A1 (de) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026809A1 (de) * 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005048897A1 (de) 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049954A1 (de) * 2005-10-19 2007-05-31 Sanofi-Aventis Deutschland Gmbh Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049953A1 (de) 2005-10-19 2007-04-26 Sanofi-Aventis Deutschland Gmbh Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen
FR2915197B1 (fr) * 2007-04-18 2009-06-12 Sanofi Aventis Sa Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
FR2915199B1 (fr) * 2007-04-18 2010-01-22 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
FR2915198B1 (fr) * 2007-04-18 2009-12-18 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
WO2010003624A2 (fr) 2008-07-09 2010-01-14 Sanofi-Aventis Composés hétérocycliques, leurs procédés de préparation, médicaments comprenant lesdits composés et leur utilisation
TWI469979B (zh) * 2008-12-24 2015-01-21 Bial Portela & Ca Sa 脂肪酸醯胺水解酶(faah)抑制劑、以及其藥學組成物與用途
US8329904B2 (en) 2009-05-12 2012-12-11 Hoffmann-La Roche Inc. Azacyclic derivatives
US8440710B2 (en) * 2009-10-15 2013-05-14 Hoffmann-La Roche Inc. HSL inhibitors useful in the treatment of diabetes
US8097634B2 (en) * 2010-04-15 2012-01-17 Hoffmann-La Roche Inc. Azacyclic derivatives
US8450350B2 (en) * 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
US8722721B2 (en) * 2011-03-16 2014-05-13 Hoffmann-La Roche Inc. SEC-hydroxycyclohexyl derivatives
US8703807B2 (en) * 2011-03-17 2014-04-22 Hoffmann-La Roche Inc. Azaspirodecanone compounds
US8809384B2 (en) * 2011-03-25 2014-08-19 Hoffmann-La Roche Inc. Azaspirodecanone compounds
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
GB201321740D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
WO2015089137A1 (fr) 2013-12-11 2015-06-18 Karos Pharmaceuticals, Inc. Acylguanidines comme inhibiteurs de la tryptophan hydroxylase
WO2016109501A1 (fr) 2014-12-30 2016-07-07 Karos Pharmaceuticals, Inc. Composés amides utilisés en tant qu'inhibiteurs de la tryptophane hydroxylase
US9611201B2 (en) 2015-03-05 2017-04-04 Karos Pharmaceuticals, Inc. Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
KR20210102887A (ko) 2018-11-14 2021-08-20 알타반트 사이언시스 게엠베하 말초 세로토닌과 관련된 질병 또는 장애를 치료하기 위한 트립토판 하이드록실라제 1 (tph1)의 결정질 스피로사이클릭 화합물 억제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1126999A (fr) * 1978-10-20 1982-07-06 Michael J. Simons Utilisation de derives de l'azole a groupe carbomoyl disubstitue en n,n, sur de l'azote cyclique, comme precurseurs pour la retenue du developpement dans des elements photographiques
US5369086A (en) * 1993-04-28 1994-11-29 Zeneca Limited N-benzotriazoles
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
CZ20032990A3 (cs) * 2001-05-05 2004-04-14 Smithkline Beecham P. L. C. N-aroylové cyklické aminy
CA2468413A1 (fr) * 2001-12-14 2003-06-26 Novo Nordisk A/S Composes ralentissant l'activite de la lipase hormono-sensible

Also Published As

Publication number Publication date
AU2003275997B8 (en) 2010-09-30
TNSN05105A1 (en) 2007-05-14
DE50306134D1 (de) 2007-02-08
HRP20050325A2 (en) 2005-06-30
RU2005114394A (ru) 2006-01-20
DE10247680B4 (de) 2005-09-01
JP4658607B2 (ja) 2011-03-23
PA8585101A1 (es) 2004-09-16
UA79994C2 (en) 2007-08-10
MXPA05003359A (es) 2005-06-22
PT1554259E (pt) 2007-02-28
ES2277152T3 (es) 2007-07-01
AU2003275997B2 (en) 2010-03-25
OA12941A (en) 2006-10-13
ECSP055729A (es) 2005-07-06
EP1554259B1 (fr) 2006-12-27
ZA200501757B (en) 2005-09-07
PE20040776A1 (es) 2004-12-24
CA2501734C (fr) 2011-05-31
JO2497B1 (en) 2009-10-05
CN1688555A (zh) 2005-10-26
UY28015A1 (es) 2004-04-30
NO20052291L (no) 2005-05-10
MY138057A (en) 2009-04-30
CA2501734A1 (fr) 2004-04-29
ATE349433T1 (de) 2007-01-15
CN100366616C (zh) 2008-02-06
HN2003000316A (es) 2006-06-12
RS51543B (sr) 2011-06-30
GT200300214A (es) 2007-02-05
JP2006509734A (ja) 2006-03-23
AR041565A1 (es) 2005-05-18
NO20052291D0 (no) 2005-05-10
TW200413335A (en) 2004-08-01
AU2003275997A1 (en) 2004-05-04
DE10247680A1 (de) 2004-04-22
SV2004001633A (es) 2004-03-19
KR20050059254A (ko) 2005-06-17
CR7717A (es) 2007-09-14
BR0315257A (pt) 2005-08-23
PL374605A1 (en) 2005-10-31
JP2011026342A (ja) 2011-02-10
HK1080473A1 (en) 2006-04-28
TWI313265B (en) 2009-08-11
IL167907A (en) 2010-12-30
WO2004035550A1 (fr) 2004-04-29
RU2325385C2 (ru) 2008-05-27
DK1554259T3 (da) 2007-05-07
RS20050207A (sr) 2007-08-03
EP1554259A1 (fr) 2005-07-20
CY1106358T1 (el) 2011-10-12

Similar Documents

Publication Publication Date Title
ATE349433T1 (de) Neue bicyclische inhibitoren der hormon sensitiven lipase
EP1499306A4 (fr) Amides bicycliques
BR0308115B1 (pt) artigo de calÇado e mÉtodo de fabricaÇço de artigo de calÇado
EP1583997A4 (fr) Elimination de photoresine
DE60330045D1 (de) Kapillarenassayvorrichtung und -verfahren
DE60301389D1 (de) Verbesserter schnittstellenklebstoff
EP1474093A4 (fr) Inhibiteurs de granzyme b
ATE318817T1 (de) Aza-arylpiperazine
ATE496940T1 (de) Ghrelin-analoga
NO20043907L (no) Partielle og fullstendige agonister av A1-adenosinreseptorer
DE50305924D1 (de) Schichtsystem
DE60322030D1 (de) Lichtempfindliches element zur benutzung als flexodruckplatte
NO20031114D0 (no) Signallys
DE60326030D1 (de) Navigationsgerät und -verfahren
DE10393305D2 (de) Liner
DE60312270D1 (de) Bowlingbahn
EP1545520A4 (fr) Inhibiteurs de cox-2 multifonctionnels
FI20022033A7 (fi) Kaukokartoitusmenetelmä
SI1554259T1 (sl) Novi biciklicni inhibitorji hormonsko senzitivne lipaze
UA6563S (uk) Комплект етикеток
UA6800S (uk) Комплект етикеток
UA6675S (uk) Комплект етикеток
UA6303S (uk) Комплект етикеток
UA6798S (uk) Комплект етикеток
UA6687S (uk) Комплект етикеток